Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Ungar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Brain Imaging and Behavior|December 3, 2013
Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interactionLeo Ungar, Andre Altmann, Michael D Greicius
Postgraduate Medicine|September 21, 2019
A challenging ECG: a case of a lengthening PR intervalDavid Sanders, Leo Ungar, Arnold H Seto
Coronary Artery Disease|July 12, 2016
Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibitionLeo Ungar, Fatima Rodriguez, Kenneth W Mahaffey
Cognitive Science|November 5, 2011
Reflection and reasoning in moral judgmentJoseph M Paxton, Leo Ungar, Joshua D Greene
Frontiers in Cardiovascular Medicine|September 15, 2018
Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is UnderstudiedLeo Ungar, David Sanders, Brian Becerra, et al.
Cleveland Clinic Journal of Medicine|July 11, 2019
Ambulatory ECG monitoring in the age of smartphonesDavid Sanders, Leo Ungar, Michael A Eskander, et al.
The American Journal of Cardiology|April 16, 2018
Racial Differences in Quality of Care and Outcomes After Acute Coronary SyndromeCelina M Yong, Leo Ungar, Freddy Abnousi, et al.
Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.
Cardiology and Therapy|August 4, 2019
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AFLeo Ungar, Fatima Rodriguez, Anne S Hellkamp, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Brain Imaging and Behavior|December 3, 2013
Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interactionLeo Ungar, Andre Altmann, Michael D Greicius
Postgraduate Medicine|September 21, 2019
A challenging ECG: a case of a lengthening PR intervalDavid Sanders, Leo Ungar, Arnold H Seto
Coronary Artery Disease|July 12, 2016
Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibitionLeo Ungar, Fatima Rodriguez, Kenneth W Mahaffey
Cognitive Science|November 5, 2011
Reflection and reasoning in moral judgmentJoseph M Paxton, Leo Ungar, Joshua D Greene
Frontiers in Cardiovascular Medicine|September 15, 2018
Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is UnderstudiedLeo Ungar, David Sanders, Brian Becerra, et al.
Cleveland Clinic Journal of Medicine|July 11, 2019
Ambulatory ECG monitoring in the age of smartphonesDavid Sanders, Leo Ungar, Michael A Eskander, et al.
The American Journal of Cardiology|April 16, 2018
Racial Differences in Quality of Care and Outcomes After Acute Coronary SyndromeCelina M Yong, Leo Ungar, Freddy Abnousi, et al.
Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.
Cardiology and Therapy|August 4, 2019
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AFLeo Ungar, Fatima Rodriguez, Anne S Hellkamp, et al.
Pageof 1